Table 3.

Sensitivity analysis censoring the NED by multivariable Cox regression for mortality by centile of TC.

	No. of patients	Events	Person-years	Incidence rate (per 10,000 py)	Age and sex-adjusted HR (95% CI)	Multivariable-adjusted HR (95% CI)
1st–5th (≤ 97 mg/dL)	3012	894	10,467	854.2	1.86 (1.71–2.02)	1.60 (1.46–1.74)
6th–20th (97–128 mg/dL)	9217	2051	32,517	630.7	1.52 (1.42–1.62)	1.29 (1.20–1.38)
21st–40th (129–151 mg/dL)	12,006	2030	44,129	460.0	1.20 (1.12–1.29)	1.08 (1.01–1.16)
41st–60th (152–171 mg/dL)	11,467	1690	42,565	397.0	1.13 (1.05–1.21)	1.06 (0.99–1.13)
61st–80th (172–196 mg/dL)	11,903	1466	44,807	327.2	Reference	Reference
81st–95th (197–233 mg/dL)	8690	996	33,300	299.1	0.96 (0.88–1.04)	1.03 (0.95–1.11)
96th–100th (> 233 mg/dL)	2922	410	11,228	365.1	1.25 (1.12–1.39)	1.35 (1.21–1.51)

Multivariable-adjusted model was adjusted for age, sex, BMI, use of lipid-lowering agents, presence of CKD, DM, and HTN, smoking status, alcohol consumption, and cancer type.

CKD chronic kidney disease, DM diabetes mellitus, HR hazard ratio, HTN hypertension, NED no evidence of disease, TC total cholesterol, CI confidence interval.